The role of health risk factors and disease on worker productivity.

The costs attributed to employee health problems are usually measured by employers in terms of direct health care costs, such as medical plan claims. Although it has been understood that employee health problems also produce indirect costs for employers, their measurement has been far less frequent. At best, studies have recorded one component of indirect health costs: the time lost to employee absenteeism and disability. The study presented here includes a measure of the actual decrease in the productivity of employees while they are on the job, in addition to measures of absenteeism and disability. These three measurements were combined to produce a Worker Productivity Index (WPI). The WPIs of 564 telephone customer-service agents were correlated with the employees' number and type of health risks, as measured by a Health Risk Appraisal. Additionally, the WPI was also examined across different disease states in the same population of employees. As the number of health risks increased, an employee's productivity decreased. The nature of the health risk may also differentially affect the pattern of the decrease. Finally, disease states were also associated with different patterns of productivity reduction.

[1]  A. Rush,et al.  Workplace performance effects from chronic depression and its treatment. , 1998, Journal of health economics.

[2]  W. Burton,et al.  Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. , 1998, Journal of occupational and environmental medicine.

[3]  D J Conti,et al.  The economic impact of depression in a workplace. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[4]  V Starbuck,et al.  Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. , 1997, Archives of internal medicine.

[5]  K. Nichol,et al.  The effectiveness of vaccination against influenza in healthy, working adults. , 1995, The New England journal of medicine.

[6]  F. Pi‐Sunyer,et al.  Medical Hazards of Obesity , 1993, Annals of Internal Medicine.

[7]  A. Jacobson,et al.  Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. , 1995, The American journal of medicine.

[8]  The effects of clonazepam on quality of life and work productivity in panic disorder. , 1997, The American journal of managed care.

[9]  D. Williamson,et al.  The 25-year health care costs of women who remain overweight after 40 years of age. , 1996, American journal of preventive medicine.

[10]  P. Jhingran,et al.  Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. , 1998, Archives of internal medicine.

[11]  C. Ryan,et al.  Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. , 1995, The American journal of medicine.

[12]  E. Wood,et al.  An Evaluation of Lifestyle Risk Factors and Absenteeism after Two Years in a Worksite Health Promotion Program , 1989, American journal of health promotion : AJHP.

[13]  J. Rizzo,et al.  Labour productivity effects of prescribed medicines for chronically ill workers. , 1996, Health economics.

[14]  D. Stempel,et al.  Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines. , 1998, The American journal of managed care.

[15]  A. Basdevant,et al.  The economic cost of obesity: the French situation. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[16]  W. Burton,et al.  Cutting the costs of migraine: role of the employee health unit. , 1998, Journal of occupational and environmental medicine.

[17]  R L Bertera,et al.  DataBase: Research and Evaluation Results , 1991, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[18]  D. Simonson,et al.  Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. , 1998, JAMA.

[19]  B. Adelsberg,et al.  Sedation and performance issues in the treatment of allergic conditions. , 1997, Archives of internal medicine.

[20]  James Campbell Quick Introduction to the measurement of stress at work. , 1998 .

[21]  P. Cryer,et al.  Hypoglycemia in IDDM , 1989, Diabetes.

[22]  P. Cryer Iatrogenic Hypoglycemia as a Cause of Hypoglycemia-Associated Autonomic Failure in IDDM: A Vicious Cycle , 1992, Diabetes.

[23]  Stan N. Finkelstein,et al.  Economic Consequences of Illness in the Workplace , 1995 .

[24]  B S Schwartz,et al.  Lost workdays and decreased work effectiveness associated with headache in the workplace. , 1997, Journal of occupational and environmental medicine.

[25]  W. Burton,et al.  Use of an Integrated Health Data Warehouse to Measure the Employer Costs of Five Chronic Disease States , 1998 .

[26]  E. Berndt,et al.  The economic burden of depression in 1990. , 1993, The Journal of clinical psychiatry.

[27]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[28]  Cary L. Cooper,et al.  Healthy Mind; Healthy Organization— A Proactive Approach to Occupational Stress , 1994 .

[29]  W N Burton,et al.  The economic costs associated with body mass index in a workplace. , 1998, Journal of occupational and environmental medicine.

[30]  E Jonsson,et al.  Economic consequences of sick-leave and early retirement in obese Swedish women. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[31]  E. Meltzer An overview of current pharmacotherapy in perennial rhinitis. , 1995, The Journal of allergy and clinical immunology.

[32]  R. Cady,et al.  Improvements in health-related quality of life with sumatriptan treatment for migraine. , 1996, The Journal of family practice.

[33]  L. George,et al.  Depression, disability days, and days lost from work in a prospective epidemiologic survey. , 1990, JAMA.

[34]  L T Yen,et al.  Prediction of prospective medical claims and absenteeism costs for 1284 hourly workers from a manufacturing company. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.